NPI: 1508930561 · ELIZABETH, NJ 07201 · Non-Pharmacy Dispensing Site · NPI assigned 11/20/2006
Authorized official STILES, SANDY controls 13+ related entities in our dataset. Read more
| Authorized Official | STILES, SANDY (SPECIAL PROJECTS LIAISON) |
| NPI Enumeration Date | 11/20/2006 |
Other providers sharing the same authorized official: STILES, SANDY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,082 | $681K |
| 2019 | 9,408 | $707K |
| 2020 | 8,696 | $620K |
| 2021 | 8,377 | $572K |
| 2022 | 8,920 | $580K |
| 2023 | 8,490 | $548K |
| 2024 | 5,221 | $504K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6,192 | 6,175 | $866K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6,910 | 6,660 | $616K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 3,619 | 3,604 | $550K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 3,796 | 3,794 | $419K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 495 | 495 | $289K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4,796 | 4,683 | $247K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2,349 | 2,319 | $197K |
| 58300 | 932 | 920 | $122K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 5,300 | 5,190 | $111K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1,571 | 1,562 | $97K |
| 99201 | 659 | 659 | $96K | |
| J7304 | Contraceptive supply, hormone containing patch, each | 1,052 | 991 | $89K |
| J7300 | Intrauterine copper contraceptive (paragard) | 128 | 128 | $82K |
| 81025 | 8,025 | 7,907 | $78K | |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | 589 | 555 | $72K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1,377 | 1,354 | $44K |
| 87806 | 1,017 | 1,015 | $42K | |
| 86703 | 2,369 | 2,367 | $42K | |
| 76830 | Ultrasound, transvaginal | 621 | 607 | $42K |
| 11981 | 297 | 297 | $36K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,257 | 3,245 | $21K |
| 58301 | 91 | 90 | $13K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 12 | 12 | $11K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 508 | 488 | $8K |
| 64435 | 92 | 92 | $5K | |
| 11982 | 48 | 48 | $5K | |
| 76857 | 91 | 91 | $4K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 14 | 14 | $4K |
| 86901 | 1,085 | 1,083 | $2K | |
| 85018 | 870 | 867 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 12 | 12 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 16 | 14 | $410.64 |
| 86780 | 660 | 641 | $366.00 | |
| 87210 | 144 | 142 | $345.60 | |
| J3490 | Unclassified drugs | 200 | 200 | $200.00 |